W. P. Carey targets 3.6% AFFO growth for 2025 with $1B-$1.5B investment plan
Q4 2024 Management View Jason Fox, CEO, highlighted the company's pivotal year, with a successful exit from the office sector and a record quarterly investment volume of $840M in Q4, bringing annual ...
W. P. Carey Inc. (WPC) Q4 2024 Earnings Call Transcript
W. P. Carey Inc. ( NYSE: WPC) Q4 2024 Earnings Conference Call February 12, 2025 11:00 AM ET Peter Sands - Head, Investor Relations Jason Fox - Chief Executive Officer Toni Sanzone - Chief Financial ...
VPG Reports Fiscal 2024 Fourth Quarter and Twelve Months Results
The Company's fourth fiscal quarter 2024 net earnings attributable to VPG stockholders were $0.8 million, or $0.06 per diluted share, compared to $4.2 million, or $0.31 per diluted share, in the ...
BioSpace16h
Lilly, Novo Skew Overall Pharma Trends With Colossal GLP-1 Sales Growth
From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved ...
Healthpeak's Portfolio Should Produce Stable Growth Regardless of Economic Conditions
As a result, Healthpeak’s life science and medical office portfolios are now prominently featured in the company's portfolio as the proceeds from the senior housing sales were reinvested into these ...
Activist Elliott confirms $2.5B-plus stake in Phillips 66, urges pipeline unit sale or spinoff
Elliott Investment Management confirms a more than $2.5B stake in Phillips 66 and will seek to streamline the company, most ...
Royalty Pharma Reports Q4 and Full Year 2024 Results
Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...
Higher Financing Costs Continue to Keep Harley Dealers and Consumers on the Sidelines
As evidence, in 2020, temporary factory shutdowns, dealer closures, and shifted product launches, led Harley to cede massive market share, down around 800 basis points, to 42% in 2020. Since then, it ...